Iron Deficiency Anemia Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Shield Therapeutics, Zeria Pharma, Keros Therapeutics

DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Iron Deficiency Anemia, historical and forecasted epidemiology as well as the Iron Deficiency Anemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Iron Deficiency Anemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Iron Deficiency Anemia Market Forecast
https://www.delveinsight.com/sample-request/iron-deficiency-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Iron Deficiency Anemia Market Report:
• The Iron Deficiency Anemia market size was valued approximately USD 1,400 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In February 2024, The new SANOIN clinical study, backed by P&G Health (the healthcare division of P&G) and carried out by top healthcare professionals, revealed that iron supplementation with Sangobion (ferrous gluconate combined with multivitamins and minerals) effectively enhances Hemoglobin (Hb) levels and quality of life (QOL), providing symptom relief. The study results indicated a notable increase in Hb levels within 14 days, symptom relief within 30 days, and improved QOL for women suffering from Iron Deficiency Anemia.
• In 2023, the United States had approximately 9,510,600 prevalent cases.
• In 2023, it was noted that Iron Deficiency Anemia was more common in females than in males, making up about 65% of the cases.
• Companies such as Akebia Therapeutics (Keryx Biopharmaceuticals) in collaboration with Japan Tobacco (through its subsidiary Torii Pharmaceutical) and Shield Therapeutics in partnership with Norgine BV have entered the Iron Deficiency Anemia (IDA) market. This market was previously dominated by over-the-counter (OTC) and prescription oral iron products (OFPs) as well as intravenous (IV) iron treatments. These companies aim to provide safer, more effective, and more convenient oral medications for IDA patients.
• Key Iron Deficiency Anemia Companies: Pharmacosmos A/S, Nemysis Ltd, Keryx Biopharmaceuticals, Pharmacosmos A/S, Tigermed Consulting Co., Ltd, Shield Therapeutics, Zeria Pharma, Keros Therapeutics, Inc., AMAG Pharma, JW Pharmaceutical, and others
• Key Iron Deficiency Anemia Therapies: Ferric Derisomaltose, Low Dose IHAT, ferric citrate, iron isomaltoside 1000 (Monofer®), Ferric carboxymaltose, Ferric Maltol, Z-213, KER-047, Ferumoxytol, venoferrum(iron sucrose), Z-213, and others
• The Iron Deficiency Anemia epidemiology based on gender analyzed that Iron Deficiency Anemia affects more females as compared to males
• The Iron Deficiency Anemia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Iron Deficiency Anemia pipeline products will significantly revolutionize the Iron Deficiency Anemia market dynamics.

Iron Deficiency Anemia Overview
Iron Deficiency Anemia (IDA) is a common type of anemia that occurs when the body lacks enough iron to produce hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. Hemoglobin is crucial for delivering oxygen from the lungs to other parts of the body and for returning carbon dioxide from the tissues back to the lungs.

Get a Free sample for the Iron Deficiency Anemia Market Report:
https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Iron Deficiency Anemia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Iron Deficiency Anemia Epidemiology Segmentation:
The Iron Deficiency Anemia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Iron Deficiency Anemia
• Prevalent Cases of Iron Deficiency Anemia by severity
• Gender-specific Prevalence of Iron Deficiency Anemia
• Diagnosed Cases of Episodic and Chronic Iron Deficiency Anemia

Download the report to understand which factors are driving Iron Deficiency Anemia epidemiology trends @ Iron Deficiency Anemia Epidemiology Forecast
https://www.delveinsight.com/sample-request/iron-deficiency-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Iron Deficiency Anemia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Iron Deficiency Anemia market or expected to get launched during the study period. The analysis covers Iron Deficiency Anemia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Iron Deficiency Anemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Iron Deficiency Anemia Therapies and Key Companies
• Ferric Derisomaltose: Pharmacosmos A/S
• Low Dose IHAT: Nemysis Ltd
• ferric citrate: Keryx Biopharmaceuticals
• iron isomaltoside 1000 (Monofer®): Pharmacosmos A/S
• Ferric carboxymaltose: Tigermed Consulting Co., Ltd
• Ferric Maltol: Shield Therapeutics
• Z-213: Zeria Pharma
• KER-047: Keros Therapeutics, Inc.
• Ferumoxytol: AMAG Pharma
• venoferrum(iron sucrose): JW Pharmaceutical
• Z-213: Zeria Pharma

Discover more about therapies set to grab major Iron Deficiency Anemia market share @ Iron Deficiency Anemia Treatment Market
https://www.delveinsight.com/sample-request/iron-deficiency-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Iron Deficiency Anemia Market Drivers
• Increasing changes in lifestyle
• Increasing cases of anemia
• Growth in geriatric population

Iron Deficiency Anemia Market Barriers
• Extensive usage of over-the-counter (OTC) medications
• Availability of generics
• Lack of robust pipeline

Scope of the Iron Deficiency Anemia Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Iron Deficiency Anemia Companies: Pharmacosmos A/S, Nemysis Ltd, Keryx Biopharmaceuticals, Pharmacosmos A/S, Tigermed Consulting Co., Ltd, Shield Therapeutics, Zeria Pharma, Keros Therapeutics, Inc., AMAG Pharma, JW Pharmaceutical, and others
• Key Iron Deficiency Anemia Therapies: Ferric Derisomaltose, Low Dose IHAT, ferric citrate, iron isomaltoside 1000 (Monofer®), Ferric carboxymaltose, Ferric Maltol, Z-213, KER-047, Ferumoxytol, venoferrum(iron sucrose), Z-213, and others
• Iron Deficiency Anemia Therapeutic Assessment: Iron Deficiency Anemia current marketed and Iron Deficiency Anemia emerging therapies
• Iron Deficiency Anemia Market Dynamics: Iron Deficiency Anemia market drivers and Iron Deficiency Anemia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Iron Deficiency Anemia Unmet Needs, KOL's views, Analyst's views, Iron Deficiency Anemia Market Access and Reimbursement

To know more about Iron Deficiency Anemia companies working in the treatment market, visit @ Iron Deficiency Anemia Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/iron-deficiency-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Iron Deficiency Anemia Market Report Introduction
2. Executive Summary for Iron Deficiency Anemia
3. SWOT analysis of Iron Deficiency Anemia
4. Iron Deficiency Anemia Patient Share (%) Overview at a Glance
5. Iron Deficiency Anemia Market Overview at a Glance
6. Iron Deficiency Anemia Disease Background and Overview
7. Iron Deficiency Anemia Epidemiology and Patient Population
8. Country-Specific Patient Population of Iron Deficiency Anemia
9. Iron Deficiency Anemia Current Treatment and Medical Practices
10. Iron Deficiency Anemia Unmet Needs
11. Iron Deficiency Anemia Emerging Therapies
12. Iron Deficiency Anemia Market Outlook
13. Country-Wise Iron Deficiency Anemia Market Analysis (2019-2032)
14. Iron Deficiency Anemia Market Access and Reimbursement of Therapies
15. Iron Deficiency Anemia Market Drivers
16. Iron Deficiency Anemia Market Barriers
17. Iron Deficiency Anemia Appendix
18. Iron Deficiency Anemia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Iron Deficiency Anemia Epidemiology https://www.delveinsight.com/report-store/iron-deficiency-anemia-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Iron Deficiency Anemia Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Iron Deficiency Anemia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Dermatitis Seborrheic Market https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market
DelveInsight's "Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Gastro Intestinal Bleeding Market https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
DelveInsight's "Gastro Intestinal Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastro Intestinal Bleeding, historical and forecasted epidemiology as well as the Gastro Intestinal Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.

Point Of Care Glucose Testing Market https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
DelveInsight's 'Point of Care Glucose Testing Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Point of Care Glucose Testing and the historical and forecasted Point of Care Glucose Testing market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Substance Drug Abuse Market https://www.delveinsight.com/report-store/substance-drug-abuse-market
DelveInsight's "Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance (Drug) Abuse, historical and forecasted epidemiology as well as the Substance (Drug) Abuse market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.